FIELD: medicine.
SUBSTANCE: what is offered is a preoperative diagnostic technique for cerebral glioblastoma. It involves computed tomography and magnetic resonant tomography. Peripheral venous blood is used to produce INF-alpha induced dendritic cells and examined for their cytotoxic activity. If the activity value is lower than 12%, glioblastoma is diagnosed.
EFFECT: invention provides non-invasive preoperative diagnosis of glioblastoma; the diagnostic technique enables estimating the adequacy of such adjuvant routines, as combined immunotherapy and anti-angiogenesis therapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRIMARY AND SECONDARY MALIGNANT BRAIN TUMORS | 2016 |
|
RU2628816C1 |
| METHOD FOR DETERMINING A SURVIVAL PREDICTION OF PATIENTS WITH BRAIN GLIOMAS GRADE 2-GRADE 4 | 2019 |
|
RU2740481C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF GLIOMAS OF HUMAN BRAIN | 2015 |
|
RU2583871C1 |
| METHOD FOR APPLYING COMBINED IMMUNOTHERAPY OF MALIGNANT BRAIN TUMORS | 2000 |
|
RU2197985C2 |
| METHOD OF DIAGNOSING PATIENTS WITH BRAIN TUMOURS | 2009 |
|
RU2411915C1 |
| BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF GLIOMAS BASED ON ANALYSIS OF GENE EXPRESSION AND MICRO-RNA | 2018 |
|
RU2709651C1 |
| METHOD OF CHEMOTHERAPY EFFICIENCY PREDICTION IN PATIENTS WITH MALIGNANT GLIOMA | 2007 |
|
RU2341794C1 |
